Prevalence and cardiac phenotype of patients with a phospholamban mutation.

Prevalence and cardiac phenotype of patients with a phospholamban mutation.

Hof, I E; van der Heijden, J F; Kranias, E G; Sanoudou, D; de Boer, R A; van Tintelen, J P; van der Zwaag, P A; Doevendans, P A.

Afiliação

Hof IE; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. i.e.hof@umcutrecht.nl.
van der Heijden JF; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Kranias EG; Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Sanoudou D; Department of Molecular Biology, Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
de Boer RA; Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
van Tintelen JP; Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
van der Zwaag PA; Department of Clinical Genetics, University Medical Center Groningen, Groningen, The Netherlands.
Doevendans PA; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Neth Heart J ; 27(2): 64-69, 2019 Feb.

Article em En | MEDLINE | ID: mdl-30547415